FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susan Cohn

Research Profile

Disorders

Living Beings

Genes & Molecular Sequences

Genes, myc

Physiology

Concepts & Ideas

Chemicals & Drugs

Anatomy

Procedures

Antineoplastic Combined Chemotherapy Protocols

Co-author Network

Publications

TOP 3
Elizabeth Sokol; Kate Feinstein; Yasmin Gosiengfiao; Paul R Haut; Peter Pytel; Susan Cohn
Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone.
Rie Suganuma; Larry L Wang; Gabriele Amann; Klaus Beiske; Susan Cohn; Catherine J Cullinane; Emanuele S G d'Amore; Claudio Gambini; Julie M Gastier-Foster; Michael D Hogarty; JA Jarzembowski; Vijay V Joshi; Wendy B London; A Thomas Look; John M Maris; Arlene Naranjo; Samuel Navarro; Julie R Park; Michel Peuchmaur; Hideki Sano; Robert C Seeger; Hiroyuki Shimada
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
Gudrun Schleiermacher; F Speleman; G P Tonini; I Ambros; P Ambros; Edward F Attiyeh; G M Brodeur; Susan Cohn; M Fischer; M Haber; J Khan; W B London; John M Maris; Katherine K Matthay; Tom Monclair; Véronique Mosseri; A Nakagawara; R Noguera; A D J Pearson
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susan Cohn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elizabeth Sokol; Kate Feinstein; Yasmin Gosiengfiao; Paul R Haut; Peter Pytel; Susan Cohn
Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone.
Pediatric blood & cancer 2013;60(3):512-4.
2013: Rie Suganuma; Larry L Wang; Gabriele Amann; Klaus Beiske; Susan Cohn; Catherine J Cullinane; Emanuele S G d'Amore; Claudio Gambini; Julie M Gastier-Foster; Michael D Hogarty; JA Jarzembowski; Vijay V Joshi; Wendy B London; A Thomas Look; John M Maris; Arlene Naranjo; Samuel Navarro; Julie R Park; Michel Peuchmaur; Hideki Sano; Robert C Seeger; Hiroyuki Shimada
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
Pediatric blood & cancer 2013;60(3):363-70.
2012: Gudrun Schleiermacher; F Speleman; G P Tonini; I Ambros; P Ambros; Edward F Attiyeh; G M Brodeur; Susan Cohn; M Fischer; M Haber; J Khan; W B London; John M Maris; Katherine K Matthay; Tom Monclair; Véronique Mosseri; A Nakagawara; R Noguera; A D J Pearson
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
British journal of cancer 2012;107(8):1418-22.
2012: Andres Eduardo Morales La Madrid; Robert Pyatt; Peter Pytel; Eva Rodriguez; Samuel Louis Volchenboum; Julie M Gastier-Foster; Cinzia Lavarino; Don Liu; Susan Cohn
Locoregional MYCN-amplified neuroblastoma.
Pediatric blood & cancer 2012;59(4):736-8.
2012: Nisha Kakodkar; Michael L Maitland; Radhika R Peddinti; Helen R Salwen; Yufeng Tian; Qiwei Yang; Alexandre Chlenski; Lisa J Guerrero; Susan Cohn
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.
Pediatric blood & cancer 2012;59(4):642-7.
2012: Peter E Zage; Chrystal U Louis; Susan Cohn
New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.
Pediatric blood & cancer 2012;58(7):1099-105.
2012: Douglas R Strother; Edward Tagge; Paul Thorner; Stanton Adkins; Garrett M Brodeur; Robert Castleberry; Margaret H Collins; Robert S Lavey; Wendy B London; John M Maris; Katherine K Matthay; Kevin Murray; C Patrick Reynolds; Mary Lou Schmidt; Hiroyuki Shimada; Susan Cohn
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(15):1842-8.
2012: Navin Robert Pinto; Susan Cohn; M Eileen Dolan
Using germline genomics to individualize pediatric cancer treatments.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(10):2791-800.
2012: Carol Jeanne Thiele; Susan Cohn
Genetically InFormed therapies--a "GIFT" for children with cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(10):2735-9.
2012: Paola Angelini; Peter F Ambros; Susan Cohn; Meredith S Irwin; Ivo Leuschner; Wendy B London; Katherine K Matthay; Tom Monclair; Andrew D J Pearson; Michel Peuchmaur; Hiroyuki Shimada; Sylvain Baruchel
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.
European journal of cancer (Oxford, England : 1990) 2012;48(8):1185-91.
2012: Andres Eduardo Morales La Madrid; Charles M Rubin; Peter Pytel; Michael Kohrman; Susan Cohn
Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
Pediatric blood & cancer 2012;58(3):472-4.
2011: Julie R Park; Victor M Santana; Jeffrey R Scott; Peter J Shaw; Clinton F Stewart; Susan Cohn; Wendy B London; Arlene Naranjo; Katherine K Matthay
Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(33):4351-7.
2011: Denah R Taggart; Peter F Ambros; Susan Cohn; Bruno De Bernardi; Steven G DuBois; Wendy B London; Tom F Monclair; Akira Nakagawara; Andrew D J Pearson; Mary Lou Schmidt; Katherine K Matthay
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(33):4358-64.
2011: Susan Cohn
Advances in the treatment of neuroblastoma.
Clinical advances in hematology & oncology : H&O 2011;9(11):865-7.
2011: Judith G Villablanca; Susan Cohn; Barry Shulkin; Sarah A Buhrow; Brenda Joyce Kitchen; Hollie Jackson; Joel M Reid; Arlene Naranjo; Paul M Sondel; Gregory Yanik; Marguerite T Parisi; Renee M McGovern; Enno Stranzinger; Patrick McGrady; Matthew M Ames; Wendy B London; C Patrick Reynolds
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(21):6858-66.
2011: Hervé J Brisse; Susan Cohn; Francesco Giammarile; Claudio Granata; Barbara Hero; Kimio Kanegawa; Michio Kaneko; K Barbara Krug; Valerie J Lewington; Wendy B London; Katherine K Matthay; M Beth McCarville; Tom Monclair; Andrew D J Pearson; Sabine Sarnacki; Matthias Schmidt; Barry L Shulkin; Sandra L Wootton-Gorges
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.
Radiology 2011;261(1):243-57.
2011: Wendy B London; Tom Monclair; Akira Nakagawara; Andrew D J Pearson; Peter F Ambros; Frank Berthold; Victoria Castel; Susan Cohn; Tomoko Iehara; Ruth L Ladenstein; Katherine K Matthay
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(24):3286-92.
2011: Michelle J Henderson; Nunzio Iraci; Chin-Kiat Kwek; Wendy B London; Glenn M Marshall; Marcia A Munoz; Jayne Murray; Giovanni Perini; Antonio Porro; Amanda J Russell; Alan C Sartorelli; Manfred Schwab; Janice Smith; Emanuele Valli; Chengyuan Xue; Lesley J Ashton; Allen B Buxton; Susan Cohn; Claudia L Flemming; Jamie I Fletcher; Samuele Gherardi; Michelle Haber; Murray D Norris
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
Journal of the National Cancer Institute 2011;103(16):1236-51.
2011: Veronica Moroz; David Machin; Andreas Faldum; Barbara Hero; Tomoko Iehara; Veronique Mosseri; Ruth Ladenstein; Bruno De Bernardi; Hervé Rubie; Frank Berthold; Katherine K Matthay; Tom Monclair; Peter F Ambros; Andrew D J Pearson; Susan Cohn; Wendy B London
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
European journal of cancer (Oxford, England : 1990) 2011;47(4):561-71.
2011: Rochelle Bagatell; Wendy B London; Lars M Wagner; Stephan D Voss; Clinton F Stewart; John M Maris; Cynthia Kretschmar; Susan Cohn
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(2):208-13.
2011: Alexandre Chlenski; Patrice G Bouyer; Lisa J Guerrero; Salida Mirzoeva; Andres Eduardo Morales La Madrid; Helen R Salwen; Yufeng Tian; Matthew Walker; David Xu; Qiwei Yang; Susan Cohn
Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone.
PloS one 2011;6(9):e23880.
2011: Tara O Henderson; Smita Bhatia; Navin Robert Pinto; Wendy B London; Patrick McGrady; Catherine Crotty; Can-Lan Sun; Susan Cohn
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(1):76-82.
2011: Nisha Kakodkar; Radhika Peddinti; Morris Kletzel; Yufeng Tian; Lisa J Guerrero; Samir D Undevia; David Geary; Alexandre Chlenski; Qiwei Yang; Helen R Salwen; Susan Cohn
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth.
Pediatric blood & cancer 2011;56(1):164-7.
2010: Suzanne Shusterman; Wendy B London; Stephen D Gillies; Jacquelyn A Hank; Stephan D Voss; Robert C Seeger; Charles Patrick Reynolds; Jennifer Kimball; Mark R Albertini; Barrett Wagner; Jacek Gan; Jens Eickhoff; Kenneth B DeSantes; Susan Cohn; Toby Hecht; Brian Gadbaw; Ralph A Reisfeld; John M Maris; Paul M Sondel
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4969-75.
2010: Alice L Yu; Andrew L Gilman; M Fevzi Ozkaynak; Wendy B London; Susan G Kreissman; Helen X Chen; Malcolm Smith; Barry Anderson; Judith G Villablanca; Katherine K Matthay; Hiro Shimada; Stephan A Grupp; Robert C Seeger; Charles Patrick Reynolds; Allen Buxton; Ralph A Reisfeld; Steven D Gillies; Susan Cohn; John M Maris; Paul M Sondel
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
The New England journal of medicine 2010;363(14):1324-34.
2010: David L Baker; Mary Lou Schmidt; Susan Cohn; John M Maris; Wendy B London; Allen Buxton; Daniel Stram; Robert P Castleberry; Hiroyuki Shimada; Anthony Sandler; Robert C Shamberger; A Thomas Look; Charles Patrick Reynolds; Robert C Seeger; Katherine K Matthay
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
The New England journal of medicine 2010;363(14):1313-23.
2010: Elizabeth Fox; John M Maris; Susan Cohn; Wendy Goodspeed; Anne Goodwin; Marie Kromplewski; Diane Medina; Hao Xiong; Andrew Krivoshik; BRIGITTE WIDEMANN; Peter Charles Adamson; FRANK BALIS
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors.
Cancer chemotherapy and pharmacology 2010;66(4):737-43.
2010: Wendy B London; Christopher N Frantz; Laura A Campbell; Robert C Seeger; Babette A Brumback; Susan Cohn; Katherine K Matthay; Robert P Castleberry; Lisa Diller
Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(24):3808-15.
2010: Katherine K Matthay; Barry L Shulkin; R Ladenstein; Jean Michon; F Giammarile; V Lewington; A D J Pearson; Susan Cohn
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
British journal of cancer 2010;102(9):1319-26.
2010: Alexandre Chlenski; Susan Cohn
Modulation of matrix remodeling by SPARC in neoplastic progression.
Seminars in cell & developmental biology 2010;21(1):55-65.
2010: Qiwei Yang; Yufeng Tian; Kelly R Ostler; Alexandre Chlenski; Lisa J Guerrero; Helen R Salwen; Lucy A Godley; Susan Cohn
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
BMC cancer 2010;10():286.
2010: Alexandre Chlenski; Lisa J Guerrero; Radhika Peddinti; Jared A Spitz; Payton T Leonhardt; Qiwei Yang; Yufeng Tian; Helen R Salwen; Susan Cohn
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.
Molecular cancer 2010;9():138.
2010: Holly J Meany; Dan L Sackett; John M Maris; Yvona Ward; Andrew Krivoshik; Susan Cohn; Seth M Steinberg; FRANK BALIS; Elizabeth Fox
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro.
Pediatric blood & cancer 2010;54(1):47-54.
2009: Chizuko Okamatsu; Wendy B London; Arlene Naranjo; Michael D Hogarty; Julie M Gastier-Foster; A Thomas Look; Michael P LaQuaglia; John M Maris; Susan Cohn; Katherine K Matthay; Robert C Seeger; Tsutomu Saji; Hiroyuki Shimada
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
Pediatric blood & cancer 2009;53(4):563-9.
2009: Samuel Louis Volchenboum; Susan Cohn
Are molecular neuroblastoma classifiers ready for prime time?
The lancet oncology 2009;10(7):641-2.
2009: Rana Zeine; Helen R Salwen; Radhika Peddinti; Yufeng Tian; Lisa Guerrero; Qiwei Yang; Alexandre Chlenski; Susan Cohn
Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(7):950-8.
2009: K Beiske; S A Burchill; Irene Y Cheung; E Hiyama; Robert C Seeger; Susan Cohn; A D J Pearson; K K Matthay
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.
British journal of cancer 2009;100(10):1627-37.
2009: Peter F Ambros; I M Ambros; G M Brodeur; M Haber; Javed Khan; A Nakagawara; G Schleiermacher; F Speleman; R Spitz; W B London; Susan Cohn; A D J Pearson; John M Maris
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
British journal of cancer 2009;100(9):1471-82.
2009: Samuel Louis Volchenboum; Susan Cohn
Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1003-4.
2009: Rochelle Bagatell; Maja Beck Popovic; Wendy B London; Yang Zhang; Andrew D J Pearson; Katherine K Matthay; Tom Monclair; Peter F Ambros; Susan Cohn
Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):365-70.
2009: Susan Cohn; Andrew D J Pearson; Wendy B London; Tom Monclair; Peter F Ambros; Garrett M Brodeur; Andreas Faldum; Barbara Hero; Tomoko Iehara; David Machin; Véronique Mosseri; Thorsten Simon; Alberto Garaventa; Victoria Castel; Katherine K Matthay
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):289-97.
2009: Tom Monclair; Garrett M Brodeur; Peter F Ambros; Hervé J Brisse; Giovanni Cecchetto; Keith Holmes; Michio Kaneko; Wendy B London; Katherine K Matthay; Jed G Nuchtern; Dietrich von Schweinitz; Thorsten Simon; Susan Cohn; Andrew D J Pearson
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):298-303.
2008: James H Feusner; A Kim Ritchey; Susan Cohn; Amy L Billett
Management of tumor lysis syndrome: need for evidence-based guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5657-8; author reply 5658-9.
2008: Steven G Dubois; Wendy B London; Yang Zhang; Katherine K Matthay; Tom Monclair; Peter F Ambros; Susan Cohn; Andrew Pearson; Lisa Diller
Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatric blood & cancer 2008;51(5):589-92.
2008: Michael J Burke; Susan Cohn
Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
Pediatric blood & cancer 2008;50(3):679-80.
2008: Jennifer Schneiderman; Wendy B London; Garrett M Brodeur; Robert P Castleberry; A Thomas Look; Susan Cohn
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):913-8.
2008: Elizabeth Fox; John M Maris; BRIGITTE WIDEMANN; Wendy Goodspeed; Anne Goodwin; Marie Kromplewski; Molly E Fouts; Diane Medina; Susan Cohn; Andrew Krivoshik; Anne Hagey; Peter Charles Adamson; FRANK BALIS
A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):1111-5.
2008: Christine Hartford; Samuel Louis Volchenboum; Susan Cohn
3 + 3 not equal to (Rolling) 6.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):170-1.
2007: Alexandre Chlenski; L J Guerrero; Qiwei Yang; Yufeng Tian; R Peddinti; Helen R Salwen; Susan Cohn
SPARC enhances tumor stroma formation and prevents fibroblast activation.
Oncogene 2007;26(31):4513-22.
2007: John M Maris; Michael D Hogarty; Rochelle Bagatell; Susan Cohn
Neuroblastoma.
Lancet 2007;369(9579):2106-20.
2007: Radhika Peddinti; Rana Zeine; Dragos Luca; Roopa Seshadri; Alexandre Chlenski; Kristina Cole; Bruce R Pawel; Helen R Salwen; John M Maris; Susan Cohn
Prominent microvascular proliferation in clinically aggressive neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3499-506.
2007: Qiwei Yang; Colleen M Kiernan; Yufeng Tian; Helen R Salwen; Alexandre Chlenski; Babette A Brumback; Wendy B London; Susan Cohn
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3191-7.
2007: Prakash N Nair; Linda McArdle; John Cornell; Susan Cohn; Raymond L Stallings
High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
Cancer genetics and cytogenetics 2007;174(2):100-10.
2007: Qiwei Yang; Yufeng Tian; Shuqing Liu; Rana Zeine; Alexandre Chlenski; Helen R Salwen; Jack Henkin; Susan Cohn
Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Cancer research 2007;67(4):1716-24.
2007: Susan Cohn
School-based practice: physical therapists collaborating with physical education teachers. Give it a try!
Physical & occupational therapy in pediatrics 2007;27(3):4.
2006: Lisa A Moreau; Patrick McGrady; Wendy B London; Hiroyuki Shimada; Susan Cohn; John M Maris; Lisa Diller; A Thomas Look; Rani E George
Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5693-7.
2006: Elizabeth Fox; John M Maris; BRIGITTE WIDEMANN; Kysa Meek; Anne Goodwin; Wendy Goodspeed; Marie Kromplewski; Molly E Fouts; Diane Medina; Steve Y Cho; Susan Cohn; Andrew Krivoshik; Anne Hagey; Peter Charles Adamson; FRANK BALIS
A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4882-7.
2006: Stephan A Grupp; Susan Cohn; Donna Wall; Charles Patrick Reynolds
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy day.
Pediatric blood & cancer 2006;46(7):719-22.
2006: Michelle Haber; Janice Smith; Sharon B Bordow; Claudia Flemming; Susan Cohn; Wendy B London; Glenn M Marshall; Murray D Norris
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1546-53.
2006: Xao X Tang; Huaqing Zhao; Bing Kung; David Y Kim; Sakeenah L Hicks; Susan Cohn; Nai-Kong V Cheung; Robert C Seeger; Audrey E Evans; Naohiko Ikegaki
The MYCN enigma: significance of MYCN expression in neuroblastoma.
Cancer research 2006;66(5):2826-33.
2006: Alexandre Chlenski; Shuqing Liu; Lisa J Guerrero; Qiwei Yang; Yufeng Tian; Helen R Salwen; Peter Zage; Susan Cohn
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
International journal of cancer. Journal international du cancer 2006;118(2):310-6.
2006: Marybeth Browne; Morris Kletzel; Susan Cohn; Roopa Seshadri; Marleta Reynolds
Excellent local tumor control regardless of extent of surgical resection after treatment on the Chicago Pilot II protocol for neuroblastoma.
Journal of pediatric surgery 2006;41(1):271-6.
2005: Rochelle Bagatell; Pavlina Rumcheva; Wendy B London; Susan Cohn; A Thomas Look; Garrett M Brodeur; Christopher Frantz; Vijay Joshi; Paul Thorner; P V Rao; Robert P Castleberry; Laura C Bowman
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8819-27.
2005: Edward F Attiyeh; Wendy B London; Yael P Mossé; Qun Wang; Cynthia Winter; Deepa Khazi; Patrick W McGrady; Robert C Seeger; A Thomas Look; Hiroyuki Shimada; Garrett M Brodeur; Susan Cohn; Katherine K Matthay; John M Maris
Chromosome 1p and 11q deletions and outcome in neuroblastoma.
The New England journal of medicine 2005;353(21):2243-53.
2005: Wendy B London; Luca Boni; Thorsten Simon; Frank Berthold; Clare Twist; Mary Lou Schmidt; Robert P Castleberry; Katherine K Matthay; Susan Cohn; Bruno De Bernardi
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.
Cancer letters 2005;228(1-2):257-66.
2005: Marina Pajic; Murray D Norris; Susan Cohn; Michelle Haber
The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome.
Cancer letters 2005;228(1-2):241-6.
2005: Bruno De Bernardi; Walentyna Balwierz; Joanna Bejent; Susan Cohn; Maria Luisa Garrè; Tomoko Iehara; Dominique Plantaz; Thorsten Simon; Paola Angelini; Armando Cama; Wendy B London; Kim Kramer; Howard M Katzenstein; Paolo Tortori-Donati; Andrea Rossi; Giulio J D'Angio; Audrey E Evans
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects.
Cancer letters 2005;228(1-2):283-99.
2005: Shuqing Liu; Yufeng Tian; Alexandre Chlenski; Qiwei Yang; Helen R Salwen; Susan Cohn
'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.
Cancer letters 2005;228(1-2):125-31.
2005: Florence Menegaux; Andrew F Olshan; Pamela Reitnauer; Julie Blatt; Susan Cohn
Positive association between congenital anomalies and risk of neuroblastoma.
Pediatric blood & cancer 2005;45(5):649-55.
2005: Wendy B London; Robert P Castleberry; K K Matthay; A Thomas Look; Robert C Seeger; H Shimada; Paul Thorner; Garrett M Brodeur; John M Maris; Charles Patrick Reynolds; Susan Cohn
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6459-65.
2005: Rani E George; Wendy B London; Susan Cohn; John M Maris; Cynthia S Kretschmar; Lisa Diller; Garrett M Brodeur; Robert P Castleberry; A Thomas Look
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6466-73.
2005: Stephen J Qualman; Jay Bowen; Patrick L Fitzgibbons; Susan Cohn; Hiroyuki Shimada
Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors.
Archives of pathology & laboratory medicine 2005;129(7):874-83.
2005: Murray D Norris; Janice Smith; Kara Tanabe; Peter J Tobin; Claudia Flemming; George L Scheffer; peter wielinga; Susan Cohn; Wendy B London; Glenn M Marshall; John D Allen; Michelle Haber
Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.
Molecular cancer therapeutics 2005;4(4):547-53.
2005: Shuqing Liu; Yufeng Tian; Alexandre Chlenski; Qiwei Yang; Peter Zage; Helen R Salwen; Susan E Crawford; Susan Cohn
Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.
The American journal of pathology 2005;166(3):891-900.
2004: Qiwei Yang; Peter Zage; David Kagan; Yufeng Tian; Roopa Seshadri; Helen R Salwen; Shuqing Liu; Alexandre Chlenski; Susan Cohn
Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8493-500.
2004: Susan Cohn; Deborah A Tweddle
MYCN amplification remains prognostically strong 20 years after its "clinical debut".
European journal of cancer (Oxford, England : 1990) 2004;40(18):2639-42.
2004: Alexandre Chlenski; Shuqing Liu; Lisa J Baker; Qiwei Yang; Yufeng Tian; Helen R Salwen; Susan Cohn
Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Cancer research 2004;64(20):7420-5.
2004: Howard M Katzenstein; Susan Cohn; Richard M Shore; Dianna M E Bardo; Paul R Haut; Marie Olszewski; Jennifer Schmoldt; Dachao Liu; Alfred W Rademaker; Morris Kletzel
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3909-15.
2004: Andrew D Campbell; Susan Cohn; Marleta Reynolds; Roopa Seshadri; Elaine Morgan; Grant Geissler; Alfred Rademaker; Maryanne H Marymount; John A Kalapurakal; Paul R Haut; Reggie Duerst; Morris Kletzel
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2885-90.
2004: Qiwei Yang; Shuqing Liu; Yufeng Tian; Chiler Hasan; Donna Kersey; Helen R Salwen; Alexandre Chlenski; Elizabeth J. Perlman; Susan Cohn
Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma.
Cancer research 2004;64(13):4531-8.
2004: Timothy J Bos; Susan Cohn; H K Kleinman; J E Murphy-Ulrich; O L Podhajcer; Sandra Rempel; Jeremy Rich; J T Rutka; E H Sage; E W Thompson
International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions.
Matrix biology : journal of the International Society for Matrix Biology 2004;23(1):63-9.
2004: Chitra F Manohar; James A Bray; Helen R Salwen; Janice Madafiglio; Andy Cheng; Claudia Flemming; Glenn M Marshall; Murray D Norris; Michelle Haber; Susan Cohn
MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.
Oncogene 2004;23(3):753-62.
2003: Qiwei Yang; Shuqing Liu; Yufeng Tian; Helen R Salwen; Alexandre Chlenski; Joanna Weinstein; Susan Cohn
Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.
Cancer research 2003;63(19):6299-310.
2003: Alexandre Chlenski; Shuqing Liu; Susan Cohn
The regulation of angiogenesis in neuroblastoma.
Cancer letters 2003;197(1-2):47-52.
2003: Joanna L Weinstein; Howard M Katzenstein; Susan Cohn
Advances in the diagnosis and treatment of neuroblastoma.
The oncologist 2003;8(3):278-92.
2002: Alexandre Chlenski; Shuqing Liu; Susan E Crawford; Olga V Volpert; George Henry De Vries; Amy Evangelista; Qiwei Yang; Helen R Salwen; Robert Gerard Farrer; James Bray; Susan Cohn
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
Cancer research 2002;62(24):7357-63.
2002: Morris Kletzel; Howard M Katzenstein; Paul R Haut; Alice L Yu; Elaine Morgan; Marleta Reynolds; Grant Geissler; Maryanne H Marymount; Dachao Liu; John A Kalapurakal; Richard M Shore; Dianna M E Bardo; Jennifer Schmoldt; Alfred W Rademaker; Susan Cohn
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2284-92.
2002: Chitra F Manohar; Marc L Short; Anthony Nguyen; Nadine N Nguyen; Daniel Chagnovich; Qiwei Yang; Susan Cohn
HuD, a neuronal-specific RNA-binding protein, increases the in vivo stability of MYCN RNA.
The Journal of biological chemistry 2002;277(3):1967-73.
2001: Motoko Omura-Minamisawa; Mitchell B Diccianni; RC Chang; Ayse Batova; LJ Bridgeman; J Schiff; Susan Cohn; W B London; Alice L Yu
p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3481-90.
2001: Prasad Mathew; Marcus B Valentine; Laura C Bowman; ST Rowe; MB Nash; Virginia Valentine; Susan Cohn; Robert P Castleberry; Garrett M Brodeur; A Thomas Look
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.
Neoplasia (New York, N.Y.) 2001;3(2):105-9.
2001: Peter H Shaw; Susan Cohn; Elaine R Morgan; P Kovarik; Paul R Haut; Morris Kletzel; S B Murphy
Natural killer cell lymphoma: report of two pediatric cases, therapeutic options, and review of the literature.
Cancer 2001;91(4):642-6.
2001: Howard M Katzenstein; P M Kent; Wendy B London; Susan Cohn
Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1047-55.
2001: Murray D Norris; J Gilbert; S A Smith; Glenn M Marshall; Helen R Salwen; Susan Cohn; Michelle Haber
Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumours.
Medical and pediatric oncology 2001;36(1):48-51.
2001: Howard M Katzenstein; Helen R Salwen; Nadine N Nguyen; D Meitar; Susan Cohn
Antiangiogenic therapy inhibits human neuroblastoma growth.
Medical and pediatric oncology 2001;36(1):190-3.
2001: Julie L Daniels; Andrew F Olshan; Kay Teschke; Irva Hertz-Picciotto; David A Savitz; Julie Blatt; Melissa L Bondy; Joseph P Neglia; Bradley Pollock; Susan Cohn; AT Look; Robert C Seeger; Robert P Castleberry
Residential pesticide exposure and neuroblastoma.
Epidemiology (Cambridge, Mass.) 2001;12(1):20-7.
2000: Xao X Tang; Huaqing Zhao; Marjorie E Robinson; Avital Cnaan; W London; Susan Cohn; Nai-Kong V Cheung; Garrett M Brodeur; Audrey E Evans; Naohiko Ikegaki
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.
Medical and pediatric oncology 2000;35(6):656-8.
2000: D Huang; JL Rutkowski; Garrett M Brodeur; P M Chou; Janet Kwiatkowski; A Babbo; Susan Cohn
Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo.
Medical and pediatric oncology 2000;35(6):590-2.
2000: D Huang; JL Rutkowski; Garrett M Brodeur; P M Chou; Janet Kwiatkowski; A Babbo; Susan Cohn
Schwann cell-conditioned medium inhibits angiogenesis.
Cancer research 2000;60(21):5966-71.
2000: Susan Cohn; Wendy B London; D Huang; Howard M Katzenstein; Helen R Salwen; T Reinhart; Janice Madafiglio; Glenn M Marshall; Murray D Norris; Michelle Haber
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21):3604-13.
2000: M Gardaneh; J Gilbert; Michelle Haber; Murray D Norris; Susan Cohn; Mary Lou Schmidt; Glenn M Marshall
Synergy between 5' and 3' flanking regions of the human tyrosine hydroxylase gene ensures specific, high-level expression in neuroblastoma cells.
Neuroscience letters 2000;292(3):147-50.
2000: Xao X Tang; Huaqing Zhao; Marjorie E Robinson; B Cohen; Avital Cnaan; W London; Susan Cohn; Nai-Kong V Cheung; Garrett M Brodeur; Audrey E Evans; Naohiko Ikegaki
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10936-41.
2000: Qiwei Yang; Andrew F Olshan; Melissa L Bondy; N R Shah; Bradley Pollock; Robert C Seeger; AT Look; Susan Cohn
Parental smoking and alcohol consumption and risk of neuroblastoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(9):967-72.
2000: Howard M Katzenstein; Susan Cohn; S Crawford; D Meitar
Angiogenesis in neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2789-91.
2000: CS Alvarado; Wendy B London; A Thomas Look; Garrett M Brodeur; D H Altmiller; Paul Thorner; Vijay V Joshi; ST Rowe; MB Nash; E Ide Smith; Robert P Castleberry; Susan Cohn
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Journal of pediatric hematology/oncology 2000;22(3):197-205.
2000: M Kletzel; D Meitar; M El-Youssef; Susan Cohn
Gastrointestinal relapse of leukemia, mimicking acute graft vs. host disease, following a stem cell transplant.
Medical and pediatric oncology 2000;34(4):287-9.
1999: Howard M Katzenstein; Alfred W Rademaker; Christof Senger; Helen R Salwen; Nadine N Nguyen; P S Thorner; L Litsas; Susan Cohn
Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4273-8.
1999: Andrew F Olshan; Jennifer Smith; M N Cook; Seymour Grufferman; Bradley Pollock; Daniel O Stram; Robert C Seeger; AT Look; Susan Cohn; Robert P Castleberry; Melissa L Bondy
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group.
American journal of epidemiology 1999;150(9):930-8.
1999: Susan Cohn
Diagnosis and classification of the small round-cell tumors of childhood.
The American journal of pathology 1999;155(1):11-5.
1999: Xao X Tang; Audrey E Evans; Huaqing Zhao; Avital Cnaan; W London; Susan Cohn; Garrett M Brodeur; Naohiko Ikegaki
High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1491-6.
1999: ML Hoover; L C Bowman; S E Crawford; C Stack; James S Donaldson; J J Grayhack; T Tomita; Susan Cohn
Long-term outcome of patients with intraspinal neuroblastoma.
Medical and pediatric oncology 1999;32(5):353-9.
1999: Michelle Haber; Sharon B Bordow; J Gilbert; Janice Madafiglio; Maria Kavallaris; Glenn M Marshall; Eugene Mechetner; J P Fruehauf; L Tee; Susan Cohn; Helen R Salwen; Mary Lou Schmidt; Murray D Norris
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells.
Oncogene 1999;18(17):2777-82.
1999: X T Kong; Virginia Valentine; ST Rowe; Marcus B Valentine; ST Ragsdale; B G Jones; D A Wilkinson; Garrett M Brodeur; Susan Cohn; A Thomas Look
Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.
Neoplasia (New York, N.Y.) 1999;1(1):80-9.
1999: Y Perel; J Conway; Morris Kletzel; J Goldman; S Weiss; A Feyler; Susan Cohn
Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
Journal of pediatric hematology/oncology 1999;21(1):13-8.
1998: H Komuro; Marcus B Valentine; ST Rowe; Vincent J Kidd; S Makino; Garrett M Brodeur; Susan Cohn; A Thomas Look
Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma.
Journal of pediatric surgery 1998;33(11):1695-8.
1998: Howard M Katzenstein; Laura C Bowman; Garrett M Brodeur; Paul Thorner; Vijay V Joshi; E Ide Smith; A Thomas Look; ST Rowe; MB Nash; T Holbrook; C Alvarado; P V Rao; Robert P Castleberry; Susan Cohn
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2007-17.
1998: Paul R Haut; Susan Cohn; Elaine Morgan; M Hubbell; KE Danner-Koptik; Marie Olszewski; M Schaff; Morris Kletzel
Efficacy of autologous peripheral blood stem cell (PBSC) harvest and engraftment after ablative chemotherapy in pediatric patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):38-42.
1998: Howard M Katzenstein; Susan Cohn
Advances in the diagnosis and treatment of neuroblastoma.
Current opinion in oncology 1998;10(1):43-51.
1997: Robert P Castleberry; J Pritchard; P Ambros; F Berthold; Garrett M Brodeur; V Castel; Susan Cohn; Bruno De Bernardi; C Dicks-Mireaux; D Frappaz; Gerald M Haase; M Haber; D R Jones; Vijay V Joshi; M Kaneko; J T Kemshead; P Kogner; R E Lee; Katherine K Matthay; J M Michon; R Monclair; Borghild Roald; Robert C Seeger; Peter Shaw; J J Shuster
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2113-6.
1997: D Chagnovich; Susan Cohn
Activity of a 40 kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2064-7.
1997: Murray D Norris; Sharon B Bordow; PS Haber; Glenn M Marshall; Maria Kavallaris; Janice Madafiglio; Susan Cohn; Helen R Salwen; Mary Lou Schmidt; DR Hipfner; SUSAN COLE; Roger G Deeley; Michelle Haber
Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1911-6.
1997: Susan Cohn; T J Moss; ML Hoover; Howard M Katzenstein; Paul R Haut; Elaine R Morgan; A A Green; Morris Kletzel
Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue.
Bone marrow transplantation 1997;20(7):543-51.
1997: C Russo; Susan Cohn; M J Petruzzi; Pedro A. De Alarcon
Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
Medical and pediatric oncology 1997;28(4):284-8.
1997: Laura C Bowman; Robert P Castleberry; A Cantor; Vijay Joshi; Susan Cohn; E Ide Smith; Alice L Yu; Garrett M Brodeur; F A Hayes; A Thomas Look
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Journal of the National Cancer Institute 1997;89(5):373-80.
1997: L A Goodman; B C Liu; Carol Jeanne Thiele; Mary Lou Schmidt; Susan Cohn; Joyce Yamashiro; D S Pai; Naohiko Ikegaki; R K Wada
Modulation of N-myc expression alters the invasiveness of neuroblastoma.
Clinical & experimental metastasis 1997;15(2):130-9.
1997: Susan Cohn; D Meitar; M Kletzel
Neuroblastoma: solving a biologic puzzle.
Cancer treatment and research 1997;92():125-62.
1996: D Chagnovich; B E Fayos; Susan Cohn
Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma.
The Journal of biological chemistry 1996;271(52):33587-91.
1996: D Chagnovich; Susan Cohn
Binding of a 40-kDa protein to the N-myc 3'-untranslated region correlates with enhanced N-myc expression in human neuroblastoma.
The Journal of biological chemistry 1996;271(52):33580-6.
1996: H Kuroda; Peter White; Erik P Sulman; C F Manohar; J L Reiter; Susan Cohn; Garrett M Brodeur
Physical mapping of the DDX1 gene to 340 kb 5' of MYCN.
Oncogene 1996;13(7):1561-5.
1996: K B Gunning; Susan Cohn; Gail Tomlinson; Louise C Strong; Vicki Huff
Analysis of possible WT1 RNA processing in primary Wilms tumors.
Oncogene 1996;13(6):1179-85.
1996: Michael A Reale; Miguel Reyes-Mugica; W E Pierceall; M C Rubinstein; L Hedrick; Susan Cohn; A Nakagawara; G M Brodeur; Eric R Fearon
Loss of DCC expression in neuroblastoma is associated with disease dissemination.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(7):1097-102.
1996: D Meitar; Susan E Crawford; A W Rademaker; Susan Cohn
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):405-14.
1996: Murray D Norris; Sharon B Bordow; G M Marshall; Paul S Haber; Susan Cohn; Michelle Haber
Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.
The New England journal of medicine 1996;334(4):231-8.
1996: C F Manohar; Helen R Salwen; Manohar R Furtado; Susan Cohn
Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1996;17(1):34-47.
1995: C F Manohar; Helen R Salwen; Garrett M Brodeur; Susan Cohn
Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
Genes, chromosomes & cancer 1995;14(3):196-203.
1995: J W Jaureguito; J F Wilcox; Susan Cohn; Ronald A Thisted; Bruce Reider
A comparison of intraarticular morphine and bupivacaine for pain control after outpatient knee arthroscopy. A prospective, randomized, double-blinded study.
The American journal of sports medicine 1995;23(3):350-3.
1995: Susan Cohn; A Thomas Look; Vijay V Joshi; T Holbrook; Helen R Salwen; D Chagnovich; L Chesler; ST Rowe; Marcus B Valentine; H Komuro
Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cancer research 1995;55(4):721-6.
1994: R L Saylors; Susan Cohn; Elaine R Morgan; G M Brodeur
Prenatal detection of neuroblastoma by fetal ultrasonography.
The American journal of pediatric hematology/oncology 1994;16(4):356-60.
1994: P S Koh; J G Raffensperger; S Berry; M B Larsen; H S Johnstone; P Chou; S R Luck; M Hammer; Susan Cohn
Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
The Journal of pediatrics 1994;125(5 Pt 1):712-6.
1994: Susan Cohn; M Hamre; Morris Kletzel; P Chou; M A Radkowski
Intraspinal Wilms' tumor metastases.
Cancer 1994;73(9):2444-9.
1994: Mary Lou Schmidt; Helen R Salwen; C F Manohar; Naohiko Ikegaki; Susan Cohn
The biological effects of antisense N-myc expression in human neuroblastoma.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(2):171-8.
1994: J M Cheng; J L Hiemstra; S S Schneider; BA Kaufman; Anna K Naumova; Nai-Kong V Cheung; Susan Cohn; L Diller; Carmen Sapienza; Garrett M Brodeur
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Progress in clinical and biological research 1994;385():43-9.
1994: C F Manohar; Helen R Salwen; Manohar R Furtado; Susan Cohn
Retinoic acid induced expression of homeobox genes in human neuroblastoma cells.
Progress in clinical and biological research 1994;385():229-35.
1993: Mary Lou Schmidt; Helen R Salwen; D Chagnovich; K D Bauer; Susan E Crawford; Susan Cohn
Evidence for molecular heterogeneity in human ganglioneuroblastoma.
Pediatric pathology / affiliated with the International Paediatric Pathology Association 1993;13(6):787-96.
1993: C F Manohar; Manohar R Furtado; Helen R Salwen; Susan Cohn
Hox gene expression in differentiating human neuroblastoma cells.
Biochemistry and molecular biology international 1993;30(4):733-41.
1993: J M Cheng; J L Hiemstra; S S Schneider; Anna K Naumova; Nai-Kong V Cheung; Susan Cohn; L Diller; Carmen Sapienza; Garrett M Brodeur
Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Nature genetics 1993;4(2):191-4.
1992: H Miwa; Gail Tomlinson; Charles F Timmons; Vicki Huff; Susan Cohn; Louise C Strong; Grady F Saunders
RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Journal of the National Cancer Institute 1992;84(3):181-7.
1991: J Foley; Susan Cohn; Helen R Salwen; D Chagnovich; J Cowan; K L Mason; Linda M Parysek
Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
Cancer research 1991;51(23 Pt 1):6338-45.
1991: Susan Cohn
Response of patients with myelofibrosis to megadose methylprednisolone.
Clinical pediatrics 1991;30(10):605.
1991: C C Ton; Vicki Huff; K M Call; Susan Cohn; Louise C Strong; David E Housman; Grady F Saunders
Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus.
Genomics 1991;10(1):293-7.
1991: S B Murphy; Susan Cohn; A W Craft; W G Woods; T Sawada; R P Castleberry; H L Levy; P C Prorok; G D Hammond
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
Lancet 1991;337(8737):344-6.
1991: Susan Cohn; Helen R Salwen; M W Quasney; Naohiko Ikegaki; J M Cowan; C V Herst; B Sharon; R H Kennett; Steven T Rosen
High levels of N-myc protein in a neuroblastoma cell line lacking N-myc amplification.
Progress in clinical and biological research 1991;366():21-7.
1991: Susan Cohn; R A Cohn; P Chou; J S Donaldson; C B Langman
Infantile myelofibrosis with nephromegaly secondary to myeloid metaplasia.
Clinical pediatrics 1991;30(1):59-61.
1990: Susan Cohn; Helen R Salwen; M W Quasney; Naohiko Ikegaki; J M Cowan; C V Herst; R H Kennett; Steven T Rosen; J A DiGiuseppe; Garrett M Brodeur
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Oncogene 1990;5(12):1821-7.
1990: Susan Cohn; A W Rademaker; Helen R Salwen; W A Franklin; F Gonzales-Crussi; Steven T Rosen; K D Bauer
Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
The American journal of pathology 1990;136(5):1043-52.
1988: Susan Cohn; Helen R Salwen; C V Herst; H S Maurer; M L Nieder; Elaine R Morgan; Steven T Rosen
Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus.
Cancer 1988;62(4):723-6.
1988: Susan Cohn
Neuroblastoma update: prognostic factors.
Journal of the Association of Pediatric Oncology Nurses 1988;5(1-2):28-9.
1987: Susan Cohn; C V Herst; H S Maurer; Steven T Rosen
N-myc amplification in an infant with stage IVS neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(9):1441-4.
1987: Susan Cohn; Elaine R Morgan; L E Mallette
The spectrum of metabolic bone disease in lymphoblastic leukemia.
Cancer 1987;59(2):346-50.